Agoracom Blog Home

Posts Tagged ‘Hemp’

NORTHBUD $NBUD.ca – Virtual 4/20: How the #Cannabis Industry Is Adapting Its Signature Holiday for Quarantine $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:30 PM on Monday, April 20th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Virtual 4/20: How the Cannabis Industry Is Adapting Its Signature Holiday for Quarantine

Dispensaries get creative, and celebrities join in, as gatherings give way to livestreams

  • Despite all the gloom facing society as 4/20 approaches, it’s predicted to be a massive sales day, contributing to what BDS Analytics thinks will be a 30% jump in retail cannabis sales this year to $17 billion.

  By T.L. Stanley Harvest House of Cannabis  

Many cannabis fans are as devoted to their unofficial holiday, April 20, as some people are to Christmas, Halloween or the Fourth of July. In recent years, as cannabis has grown in mainstream acceptance and legality, 4/20 has been marked with parties and concerts, stadium-sized festivals and pot versions of pub crawls.

But not this year, as the coronavirus response has blocked public gatherings, gutted the experiential industry, canceled nearly every major 4/20 event and substantially altered marketers’ approaches  to the day.

The celebrations will go on, though, as organizers pivot from real-world to virtual gatherings, lining up talent like Wiz Khalifa, Billy Ray Cyrus, Berner and Kid Astronaut for marathon live streams that revelers can watch from the safety of their couches.

Delivery services are prepped for heavy volume in the wake of a record-setting mid-March sales surge, and brands in the space are giving consumers quarantine-friendly ideas to replace their usual in-person meetups and smokeouts. “This is a chance for the cannabis community to model to the rest of the world how holidays should be handled during periods of social crisis.” —Steve DeAngelo, co-founder, Harborside dispensary

Dispensaries in states where they’re considered “essential businesses”—and therefore allowed to stay open, while following strict safety protocols and social distancing rules—are leaning into their curbside pickup and contactless delivery options. They’ll be trying to discourage exactly the kinds of crowds at their venues that they’ve actively fostered in the past.

Mainstream, non-cannabis brands that have latched onto the holiday with psychedelic stoner-cliched ads and memes may sit it out all together, similar to this year’s approach to April Fools’ Day, so as not to appear flip or insensitive (or simply wasteful with their resources) during the current pandemic and economic downturn.

All things considered, 4/20 is expected to shed some of the raucous overkill and “amateur night” feel of the recent past in favor of a more thoughtful, subdued vibe.  

“You don’t generally associate 4/20 with restraint,” says Steve DeAngelo, a longtime cannabis activist and co-founder of the Harborside dispensary chain in the Bay Area. “But this is a chance for the cannabis community to model to the rest of the world how holidays should be handled during periods of social crisis.”

Taking no chances, the mayor of San Francisco has publicly warned cannabis devotees not to travel to or gather in the famously open-minded destination, known for its 4/20 meet-ups in places like Golden Gate Park. “We will cite people. We will arrest people if necessary,” London Breed says in an Instagram video. And the Washington State Liquor and Cannabis Board sent out a list of do’s and don’ts to licensed businesses, telling them not to schedule events, hire food trucks or live bands or try in any way to attract large crowds.

Another green rush

Despite all the gloom facing society as 4/20 approaches, it’s predicted to be a massive sales day, contributing to what BDS Analytics thinks will be a 30% jump in retail cannabis sales this year to $17 billion. 

One of the previous high water marks for the industry was April 20, 2019, when recreational cannabis sales increased more than 100%, versus the prior week, in states like California, Colorado, Nevada and Washington, according to cannabis data firm Headset.

“Since 4/20 is on a Monday this year, the sales uptick could start over the weekend or maybe even mid-week,” says Liz Connors, Headset’s director of analytics.

Weedmaps, a national cannabis delivery platform, is girding for a second green rush, following the March spike in sales as stay-at-home mandates were announced. “Conservative estimates could very well put us around eight times the order volume over our baseline, and four to five times what we typically see on this holiday annually,” according to CMO Juanjo Feijoo.

Source: https://www.adweek.com/creativity/virtual-4-20-how-the-cannabis-industry-is-adapting-its-signature-holiday-for-quarantine/

MOTA Ventures $MOTA.ca Generates $4.29 Million in Revenue During March 2020 $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 9:23 AM on Monday, April 20th, 2020
Mota large
  • Generated CAN$4,290,000 with related expenses of $4,240,000
  • The Immune Support product line experienced further positive growth contributing to First Class acquiring 20,959 new customers during the month of March

VANCOUVER, BC / ACCESSWIRE / April 18, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company“) is excited to announce that for the month of March 2020, its First Class CBD brand achieved sales of Cdn$4,290,000, with related expenses of Cdn$4,240,000. Customer acquisition expenses for March 2020 include one-time costs of approximately Cdn$1,160,000 associated with the introduction of the new line of Immune Support and CBD products. The Immune Support product line experienced further positive growth contributing to First Class acquiring 20,959 new customers during the month of March. The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. The Company also launched an Immune CBD oil, along with an Elderberry Gummy product. The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Sales for March 2020 compare to sales of Cdn$1,280,000 during the same period last year, representing an increase of 235%.

The Company also introduced a new brand, Nature’s Exclusive CBD, in the first week of April 2020. The Nature’s Exclusive CBD brand will offer a range of products, which include the new Immune CBD oil, Elderberry gummies, CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.

First Class offers a CBD hemp-oil formulation intended to provide users with therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. First Class offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee. First Class plans to continue its significant growth in their U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am extremely pleased with the performance of our business during March 2020, a month where the world and the economy faced immeasurable challenges. Our ability to efficiently innovate and launch new products, is a perfect example of our primary competitive advantage, and what allows us to be a leader in the ecommerce space. We expect our investment in accelerated customer acquisition from February to March, including a one-time cost of Cdn$1,160,000, will continue to produce significant revenue growth, and are hopeful it will lead to increased profitability in the upcoming months,” stated Ryan Hoggan, CEO of the Company.

The Company cautions that figures for revenue, expenses and margin generated from the sale of First Class CBD products have not been audited, and are based on calculations prepared by management. Actual results may differ from those reported in this release once these figures have been audited. These figures were translated from US dollars into Canadian dollars using the Bank of Canada monthly average exchange rate of US$1.00:Cdn$1.3953 for March 2020 and US$1.00:Cdn$1.3368 for March 2019.

About Mota Ventures Corp.

Mota is an established ecommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the Company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Hollister Biosciences Inc.$HOLL.ca Division Hollister #Cannabis Co Becomes Official Brand Partner for Chronic Relief 4/20 Fundraiser in Support of Feeding America $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:20 AM on Monday, April 20th, 2020
  • Through its Hollister Cannabis Co division, has become an official brand partner of Farechild Events’ Chronic Relief 4/20 fundraiser.
  • Virtual event has been established to help the Feeding America network of food banks as they support communities and families impacted by the COVID-19 pandemic.

Hollister Biosciences Inc., the creator of California’s #1 hash-infused pre-roll HashBone, joins a global group of cannabis’ biggest stars for an unprecedented live web broadcast on one of the world’s “highest” holidays to feed hungry families during the global coronavirus pandemic.  

VANCOUVER, April 20, 2020  – Hollister Biosciences Inc. (CSE: HOLL, OTC: HSTRF, FRANKFURT: HOB) (the “Company” or “Hollister“) – through its Hollister Cannabis Co division, has become an official brand partner of Farechild Events’ Chronic Relief 4/20 fundraiser. 

An extraordinary line-up of game-changing cannabis personalities, activists, actors, musicians, athletes, journalists and brands have banded together for Chronic Relief – a ground-breaking free telethon live-web broadcast, with 100% of all funds raised via donation given to Feeding America COVID-19 Response Fund (501c3). This virtual event has been established to help the Feeding America network of food banks as they support communities and families impacted by the COVID-19 pandemic. Households facing hunger may be more susceptible to the virus, further contributing to the demands placed on food banks. Your donation will enable food banks to serve the most vulnerable members of the community and our neighbors in need, during this difficult time.

Uniting the global cannabis community in celebration of 4/20 by bringing entertainment, words of encouragement, and the giving spirit to those in need; famed cannabis event producers Dave Tran and James Zachodni of Farechild Events, Seattle-based Atomic Studios, lifestyle brand/canna-marketing company Dab Star and award-winning branding agency Wick & Mortar, along with others, come together to support those facing hunger as a result of COVID-19. 

The cannabis community has embraced Chronic Relief en masse by supporting the upcoming event through a wide array of platforms in an effort to ignite passion in the American people showing that cannabis cares and is here to feed your body and mind. Brands and companies who have offered to support include: Sensi Magazine, Marijuana Venture Magazine, Cannabis Club TV, Cannabis Talk 101, PufCreativ, Enlighten, Cannabis & Tech Today, Pot Brothers At Law, Cannacon, Cannabis Now Magazine, Happy Munkey, Leaf Magazine, Haze Radio, Revel, Hempfest, Dab Tabs, Futurola, 420 Games, NECann, Respect My Region, Cannabis Alliance, Daily Leaf, Sound Cultivation, LA Cannabis News, Dip Devices, My Cannabis Accountant, Scynce LED, and Chapter 2.

“We’re at the threshold of an extreme moment of need in our human existence,” said Dave Tran, organizer of the event and one of the executive producers of the Chronic Relief broadcast. “There’s countless families who are surviving this crisis hungry, scared and unsupported. We have the network, we have the passion, we have the technology to raise awareness. Most importantly Feed America needs the funding to do their incredible work during this crisis. The support we’ve received from the cannabis media and industry community is remarkable. James and I’s phones are blowing up with everyone asking, ‘What can I do and how can I help?’ We hope our viewers all over the country will do the same on 4/20.” 

Farechild Events further shared about this event: “In our current state of uncertainty, we know it’s essential to unite as a community to offer strength and optimism during this international crisis. The cannabis industry was built on the giving spirit and if there has ever been a time to harness the strength of the cannabis community, it’s now. Let’s come together to support those facing hunger as a result of the COVID-19. 

We have the opportunity to make this 4/20 the most iconic celebration in our community’s history. There is no better time than the present for the cannabis space to make a lasting impact where it matters most. As all major 4/20 celebrations have been cancelled, we have the opportunity to leverage our partnerships and vast network of supporters to capture a large audience of virtual cannabis enthusiasts in support of a virtuous cause. Cannabis consumers and advocates are looking for a way to connect with their peers on 4/20 and Chronic Relief is the answer.  

In the spirit of legendary fundraisers like the Jerry Lewis MDA Labor Day Telethon, Chronic Relief looks to bring many of the same aspects of the time-honored tradition, but in a virtual world where viewers can join a live-stream. The event will act as a platform to raise money for charity with 100% of all funds raised via donation during broadcast will be given to Feeding America (501c3). A donation link will be visible on the live-stream screen. In addition to the opportunity to donate to feedingamerica.org, viewers can expect to see video segments from artists, influencers and celebrities.  Live musical performances and interviews with influencers will stream live from our Seattle-based studio in a true variety-show format. It will be a 4/20 to remember.”

The CEO of Hollister Biosciences Inc, Carl Saling, shared: “We are honored to be part of Chronic Relief 4/20. So many families are struggling right now and we all must step up and do our part to help.  Hollister Cannabis Co has been making and donating hand sanitizer all over the community.  This event is an opportunity to come together and really do some good.”

Chronic Relief 4/20 is taking place on Monday, 4/20/20 from 12-5PM PST. For more information and to RSVP for this remarkable live-stream fundraiser, please visit farechild.com. 

The Team Behind Chronic Relief

Farechild Events is the premier event production platform focusing on the cannabis industry.

www.farechildevents.com 

Feeding America is a not for profit. As the COVID-19 pandemic continues, we are committed to serving communities and individuals facing hunger across America, wherever they are. Every dollar raised from the COVID-19 response fund will be used to get food and funds to local food banks across the US. You can help make sure we can be there for our neighbors in need during this time of uncertainty. www.feedingamerica.org  

Atomic Studios is our broadcast studio partner and is located in Seattle’s South Lake Union. The studio is designed for live stream productions and includes cameras, lighting, graphics, audio, replay, and the best team in the Pacific Northwest to make it happen. www.atomicinfotech.com 

Wick & Mortar is the award-winning cannabis-focused branding and content marketing agency. Their core services include branding, strategy, copywriting, packaging design, packaging production, and website design. Additional services include marketing consulting, photography, videography, and advertising. For over 10 years, Wick & Mortar has brought a plethora of experience, deep-rooted relationships and polished presentation to some of the most recognized projects in the cannabis industry. www.wickandmortar.com 

About Hollister Biosciences Inc. 

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. 

Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website:  www.hollistercannabisco.com 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile onwww.sedar.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-inc-division-hollister-cannabis-co-becomes-official-brand-partner-for-chronic-relief-420-fundraiser-in-support-of-feeding-america-301043070.html

Empower Clinics $CBDT.ca Announces Closing of Private Placement the Launch of Immune System Tele-Medicine Services and Patient Visits Up 480% $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:22 AM on Friday, April 17th, 2020

Empower Clinics closes private placement of $653,000.00 to support the Company growth plan and goes live with physician based immune boosting tele-medicine consultations with online professional supplement dispensing

  • Recently announced digital health initiative, has added physician based tele-medicine consultations to address immune system boosting requirements for existing patients and new patients, on a nationwide basis
  • The Company clinics have also seen a 480% increase in patient visits in the first half of April 2020

VANCOUVER, BC / April 17, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company”), a vertically integrated life sciences company, is pleased to announce the closing of its non-brokered private placement of an aggregate of 16,325,000 units of the Company (each, a “Unit”) at a price of $0.04 per Unit for gross proceeds of $653,000.00 (the “Offering”).

The proceeds of the Offering are expected to be used by the Company for general working capital and corporate purposes.

The Company, as part of the recently announced digital health initiative, has added physician based tele-medicine consultations to address immune system boosting requirements for existing patients and new patients, on a nationwide basis. The Company clinics have also seen a 480% increase in patient visits in the first half of April 2020.

“Securing additional capital provides our Company more flexibility to support our staff and patients, during such a difficult time in history”, said Steven McAuley, Chairman & CEO. “We are hiring physicians and administrative staff right now to meet patient demand and adding technology resources to ensure our new services are available nationwide.”

In addition, our network of physicians will now be able to dispense over 250 premium supplement products to support patients’ needs, through a new online Sun Valley Health supplement store.

“Our new telemedicine platform is extremely robust, giving us the opportunity to provide a variety of modalities to our patients.” said Dustin Klein, Director and SVP Business Development. “We are focused on helping patients boost their immune systems and reduce stress and anxiety that may arise with isolation and social distancing.”

Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.10 per Warrant Share for a period of two years following the Closing.

The Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the “Securities”), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings. None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company operating a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has its first hemp-derived CBD extraction facility under development, to produce proprietary lines of cannabidiol (CBD) based products to distribute through company owned and franchised clinics, wholesale partnerships, online channels and developing retail channels nationwide in the U.S.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

Investors: Dustin Klein
Director
dustin@svmmjcc,com
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

NORTHBUD $NBUD.ca – Ontario online #pot orders hit high, keep steady amid coronavirus-related stockpiling $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:02 PM on Thursday, April 16th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Ontario online pot orders hit high, keep steady amid coronavirus-related stockpiling

  • Cannabis stockpiling in Ontario led to some heavy sales last month, and early signs show that the demand may be sticking around.
  • Data provided by the Ontario Cannabis Store showed daily online orders hovered in the mid-2,000 range for the first half of last month, tripling when Canada moved to restrict U.S. border access and spiking to a high of nearly 14,000 when Ontario announced pot shops would be a non-essential business, requiring their temporary closure.

Ontario online pot orders hit high, keep steady amid coronavirus-related stockpiling 

Cannabis stockpiling in Ontario led to some heavy sales last month, and early signs show that the demand may be sticking around. Data provided by the Ontario Cannabis Store showed daily online orders hovered in the mid-2,000 range for the first half of last month, tripling when Canada moved to restrict U.S. border access and spiking to a high of nearly 14,000 when Ontario announced pot shops would be a non-essential business, requiring their temporary closure. Two weeks later, daily sales have held steady around the 9,000 level, almost five times the amount made prior to the start of the pandemic. While it may be too early to really gauge how COVID-19 will impact legal cannabis sales over the long term, the OCS numbers provide a highly precise glimpse at how people are consuming cannabis during the pandemic.

Source: links.mkt2011.com/servlet/MailView?ms=MzIxMzM4MzQS1&r=MjU5OTkyNTIyMjg1S0&j=MTY4MzcwMDAwMwS2&mt=1&rt=0

North Bud Farms Fuels California Growth $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:23 PM on Wednesday, April 15th, 2020
  • Fueled its California growth with the execution of definitive agreements for a master lease, operations and royalty arrangement with an experienced California-licensed operator
  • To operate the licensed facilities at the Company’s Salinas, California farm
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value

TORONTO, April 15, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its U.S. subsidiary, Bonfire Brands USA Inc., has fueled its California growth with the execution of definitive agreements (the “Agreements”) for a master lease, operations and royalty arrangement with an experienced California-licensed operator (the “Cultivator”), to operate the licensed facilities at the Company’s Salinas, California farm.

Highlights of the California Deal

  • Partnering with a proven licensed cannabis cultivator who has been operating successfully in Salinas for several years;
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value;
  • Reduces the Company’s capital expenditure requirements while still generating significant revenue and retaining a portion of the unlimited upside potential through a royalty agreement;
  • Builds EBITDA-positive operations; and
  • Access to a cost-efficient and reliable supply chain on which to build the Company’s branded product portfolio within the state of California.

Terms of the Agreement
As per the terms of the Agreements, the Cultivator will lease the Company’s Salinas farm for 5 years, with options to extend the lease for up to an additional 5 years, and Bonfire Brands USA Inc. will receive the following consideration:

  • Lease payments of USD$900,000 per year, with incremental increases if the Cultivator extends the lease beyond the initial 5 year term;
  • A royalty equal to 5% of the gross revenue generated by the Cultivator from its use of the Salinas farm; and
  • The right to acquire a significant portion of the product harvested each quarter on the farm by the Cultivator, at a 15% discount to market rate.

During the term of the Agreements, the Cultivator will be responsible for the costs of operating the farm, including but not limited to staffing, operations, repair, maintenance, licensing and compliance; moreover, the Cultivator is committed to funding and managing the build-out of up to an additional 230,000 sq. ft. of licensed cultivation space in order to maximize the revenue-generating potential of the property.

“We are very pleased to have concluded this deal as we partner with an established operator to build up our asset and to secure access to high-quality, low-cost cannabis,” said Justin Braune, President of Bonfire Brands USA. “This deal will allow the Company to immediately achieve EBITDA-positive operations at our largest facility without incurring significant capital investments. By retaining preferential purchasing terms, the Company can now focus on the success of its branded product lines, on the back of the estimated 40,000 pounds of production capacity that the Cultivator is expected to bring online over the next 24 months.”

About North Bud Farms Inc.
NORTHBUD owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada. Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution. Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, the success of its arrangement with the Cultivator to lease and operate its Salinas farm, U.S. and Canadian strategies, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]           

With greater acceptance and understanding, people know more than ever about #CBD – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 3:55 PM on Wednesday, April 15th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated cannabis company with products in 220 California dispensaries and joint ventures, licensing agreement & partnerships with global brands. The company recently closed $20 MILLION deal with Venom Extracts adding $CDN 16.4 million in revenue and $CDN 2.48 million in EBITDA. Learn More

With greater acceptance and understanding, people know more than ever about CBD. But did you know these five fascinating facts?

  • As research continues to grow, so too does the demand for CBD products
  • So much so, in fact, that the market has yielded some impressive profits in the two years since the Farm Bill was passed; which effectively legalised hemp and CBD at the federal level

By: Michael Turner

With all the hype surrounding CBD, there’s plenty of information to be had on the compound. Derived from hemp, CBD is one of 113 cannabinoids found in cannabis. Each cannabinoid interacts with our body in a specific way, and we even have specialised receptors in our nervous system to accept them.

As research continues to grow, so too does the demand for CBD products. So much so, in fact, that the market has yielded some impressive profits in the two years since the Farm Bill was passed; which effectively legalised hemp and CBD at the federal level.

Whatever you might know about CBD, there’s a good chance you don’t know these five facts. Keep reading to learn what they are, they might just surprise you.

1. It’s One Of The Fastest-Growing Industries In History: You can buy pharmaceutical grade CBD oil in stores and at several online providers all over the country. This massive spread of CBD products is due to the incredible demand for CBD and CBD-based products; causing the industry to become one of the fastest-growing in history.

Financial experts have predicted that the CBD industry has grown at around 107% per-year, and will continue to do so for the better half of the decade. People simply love CBD products, and as researchers discover more amazing benefits, the demand only grows.

The CBD industry managed to surpass the one billion dollar mark last year, and is projected to surpass 10-20 billion in the next few years. As misinformation and stigma dissipate, facts and scientific data take their place, making cannabis, hemp, and CBD better understood by everyone.

2. It Can Help Cancer Patients Manage Symptoms: CBD offers some very promising results in cancer patients. Cancer is a devastating condition where cells divide uncontrollably and destroy tissue. This can include muscle tissue, organs, blood vessels, and more. Often, cancer is incredibly painful, and the treatments available for cancer are no less uncomfortable than the disease itself.

Cannabinoids may actually help with more than just the symptoms of cancer, however. Certain studies have shown that cannabinoids, including CBD, might actually help to slow the growth of tumours. Another study found that it could potentially make cancerous cells more susceptible to radiation while not affecting healthy cells.

Overall, it would seem that CBD has the ability to inhibit cancer growth, manage symptoms, and aid in the destruction of cancerous cells. These are all great things, but further research must be conducted before these benefits can be cemented into CBD’s repertoire.

3. There’s a CBD-Based Drug Available for Seizures: Believe it or not, the FDA itself has recognised and performed research on the effectiveness of CBD in treating certain conditions, and recently approved a drug called Epidiolex, which is formulated from CBD. This breakthrough in CBD research proves that CBD is both useful and effective in medical applications.

Epidiolex is used to treat certain severe forms of epilepsy, such as Dravet Syndrome. These rare conditions can cause debilitating and often dangerous seizures. The CBD-based drug seems to reduce the number of as well as the severity of these seizures, making life more comfortable and manageable for those suffering from these conditions.

4. CBD Is Opening New Doors In Medical Research: Besides treating epilepsy and cancer, CBD is opening doors to all kinds of new research. Studies have been conducted on the compound’s effectiveness at treating or affecting conditions such as anxiety; depression; PTSD; diabetes; heart disease; high blood pressure; skin conditions; Alzheimer’s and more.

According to the Penguin CBD team, now that CBD and hemp are officially legalised, there’s plenty of room for more research and plenty of money in the industry to support new studies. With specialised receptors for cannabinoids in our nervous systems, it’s clear that our bodies are somewhat designed to accept and make use of cannabinoids, and their incredible list of benefits only continues to grow as we learn more.

CBD has yet another useful application: helping to treat addiction. Opioid-based painkillers are the cause of thousands of overdoses and deaths each year, and yet, they’re continuously prescribed without any valid alternatives available. CBD is effective at pain management but has also been shown to reduce the symptoms of withdrawal and help reduce cravings in addicts.

5. CBD Can Be Used In Pets And Children: You probably didn’t know you could give your furry friend CBD, did you? CBD pet treats are available for pets who suffer from chronic pain, inflammation, anxiety, or even have appetite problems. They’re tasty and you’re pet won’t know that they contain anything other than that yummy steak flavour they love so much!

Pet owners all over the country are choosing CBD oil to bring their pets easy comfort and relief from conditions like arthritis. While the research on pets and CBD is scarce, millions of pet owners swear by CBD and its effectiveness.

You can also give CBD to your children. In fact, there are studies available that suggest CBD may be an effective treatment for ADHD instead of giving stimulants to your child. That’s not to say you should immediately replace your child’s ADHD medication with CBD, but you can certainly talk with your child’s doctor about this natural alternative. Many parents have found CBD to be effective at managing hyperactive children and those with focus or concentration issues.

Children also suffer from chronic pain, inflammation, and conditions such as anxiety. CBD is truly an amazing compound with a myriad of useful applications, and it spans beyond just use in adults and humans. Your pets and your children can experience its benefits as well.

CBD is only growing in popularity, and you can be sure to see some more amazing benefits discovered as more money and effort go into CBD studies. With CBD’s legal status solidified, it’s not much easier to study its effects and perform clinical trials without the threat of government interference. Where will the future of CBD and CBD products will take us? The road ahead is set to be an exciting one…

Source: https://www.we-heart.com/2020/04/13/five-things-you-didnt-know-about-cbd/

INTERVIEW: After 478% Increase In Q1 Patients, Empower Clinics $CBDT.ca Adds Telemedicine Access To Physicians and E-Commerce $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:30 PM on Tuesday, April 14th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 800% in February. 590% in March and 480% for Q1.  But will Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower had to actually increase operating hours due to demand from existing patients who need their CBD medication more than ever, as well as, new patients who are experiencing anxiety and stress through the COVID-19 pandemic.

BUT THAT WASN’T ENOUGH

The Company has now entered expanded into telemedicine across multiple states for patients who can’t get to a clinic but need a consultation with doctors over the phone to determine the best CBD medications, as well as, 250 new homeopath products for their newly launched immunotherapy initiative …. all which can be fulfilled through the company’s e-commerce platform.

Oh …. and did we mention that psychedelics are on the way?  Empower Clinics has already announced its intention to expand into the field of Psilocybin and psychedelics.  The new telemedicine platform now accelerates this initiative.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into real growth.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment

Primo Nutraceuticals Inc. $PRMO.ca Announces New Product Website Launch to Support Brand Awareness Initiative into the Natural Health & Wellness Market $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:08 AM on Tuesday, April 14th, 2020
  • launched new e-commerce site that promotes brand awareness and market expansion into the natural health, wellness and hemp nutraceutical market
  • Newly designed website offers over 25 different products from 6 different brands, with insightful information on the health benefits of each product, FAQs and contact information

VANCOUVER, British Columbia, April 14, 2020 – PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce the launch of their new e-commerce site that promotes brand awareness and market expansion into the natural health, wellness and hemp nutraceutical market. The newly designed website offers over 25 different products from 6 different brands, with insightful information on the health benefits of each product, FAQs and contact information.

The company possesses proprietary formulas for cannabis edibles, topical, and tinctures with a focus on building a strong presence in the health and wellness and hemp industry with the objective of extracting and selling natural health and wellness products with and without cannabinoids (CBD) in both Canada and the United States. Brands include: PRIMO, Thrive CBD, Beauty Kitchen, Marianna Naturals, Defy and S-CELL.

The website www.primoceuticals.com will begin by offering over 25 different natural health and wellness products ranging from; Hand Sanitizers, CBD Performance drinks, Soap & Body Wash, Body & Skin Care and Hemp/CBD Oils and Gear. The website was developed in conjunction with Beauty Kitchen’s e-commerce platform to provide an easy-to-use online store for the consumer who is interested in purchasing the latest and greatest in the online natural health and wellness CBD related products. Primo has been focused on developing their new corporate and e-commerce site behind the scenes with the hopes of offering a better user experience while anticipating the increase in shareholder value. 

Andy Jagpal, President Comments:

“Our website has a clean, modern design that allows visitors to have a very informative experience with our brand as we continue to grow and increase our market presence. I encourage our shareholders to explore the website and to sign up for direct emails about new product offerings. The launch of our consumer website is a great milestone in the company’s history as we begin to offer natural health and wellness products online with and without CBD.”

About Primo Nutraceuticals

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

Corporate: www.primonutraceuticals.com


FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Mota Ventures $MOTA.ca Announces Record Number of Subscriptions Year-To-Date in March and Over 6,000 New Customers in April $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 7:38 AM on Tuesday, April 14th, 2020
Mota large
  • First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th.
  • 1,700 of the new customers purchased products from the Immune Support line.
  • MOTA experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

VANCOUVER, BC / ACCESSWIRE / April 14, 2020 / Mota Ventures Corp. (CSE:MOTA FSE:1WZ:GR OTC PINK:PEMTF) (the “Company“) is excited to announce its First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th. Additionally, during this time period over 1,700 of the new customers purchased products from the Immune Support line. During the month of March, the Company experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

The Immunity Blend is currently the Company’s top seller in the Immune Support line. The all-natural blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. The line also features Immune CBD oil containing CBD, B3, B12, Vitamin C and Zinc and Immunity Gummy Bears contain 100% natural Elderberry extract.

First Class and Nature’s Exclusive offer a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. First Class and Nature’s Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee. The Company plans to continue its significant growth in U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am pleased at the incredible number of monthly subscriptions acquired during the month of March. We continue to see overwhelming interest in our Immune Support products and higher CBD content oils. We operate a very responsive and agile business, which allows us to identify consumer trends and execute upon the demand we are seeing in the marketplace,” stated Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com